| MolName | (5Z)-3-(oxolan-2-ylmethyl)-5-[(4-oxo-2-pyrrolidin-1-ylpyrido[1,2-a]pyrimidin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C21H22N4O3S2 |
| Smiles | O=C(/C(/S1)=C/C2=C(N3CCCC3)N=C(C=CC=C3)N3C2=O)N(CC2OCCC2)C1=S |
| InChI | InChI=1S/C21H22N4O3S2/c26-19-15(12-16-20(27)25(21(29)30-16)13-14-6-5-11-28-14)18(23-8-3-4-9-23)22-17-7-1-2-10-24(17)19/h1-2,7,10,12,14H,3-6,8-9,11,13H2/t14-/m1/s1 |
| InChIK | QLBJGPQTYGUARD-CQSZACIVSA-N |
| TotalMolweight | 442.563 |
| Molweight | 442.563 |
| MonoisotopicMass | 442.113331 |
| CLogP | 0.6221 |
| CLogS | -4.461 |
| H Acceptors | 7 |
| TotalSurfaceArea | 318.78 |
| Relative PSA | 0.3254 |
| PolarSurfaceArea | 122.84 |
| Druglikeness | 5.0364 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.46667 |
| Fragments | 1 |
| Non HAtoms | 30 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| StereoCenters | 1 |
| Rotatable Bond | 4 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Sp3Atoms | 12 |
| Symmetricatoms | 2 |
| Amides | 2 |
| BasicNitrogens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (5Z)-3-(oxolan-2-ylmethyl)-5-[(4-oxo-2-pyrrolidin-1-ylpyrido[1,2-a]pyrimidin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-3-(oxolan-2-ylmethyl)-5-[(4-oxo-2-pyrrolidin-1-ylpyrido[1,2-a]pyrimidin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one